$364 Million is the total value of Tri Locum Partners LP's 41 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 102.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LLY | Buy | LILLY ELI & CO | $34,007,000 | +50.6% | 105,170 | +51.0% | 9.33% | +0.9% |
| BIIB | New | BIOGEN INC | $24,177,000 | – | 90,551 | +100.0% | 6.64% | – |
| ARGX | Sell | ARGENX SEsponsored adr | $22,649,000 | -27.7% | 64,152 | -22.5% | 6.22% | -51.6% |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $20,859,000 | – | 196,390 | +100.0% | 5.72% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $20,745,000 | – | 30,115 | +100.0% | 5.69% | – |
| CTLT | Buy | CATALENT INC | $17,028,000 | +46.6% | 235,320 | +117.4% | 4.67% | -1.7% |
| GH | Buy | GUARDANT HEALTH INC | $15,393,000 | +98.4% | 285,948 | +48.7% | 4.22% | +33.0% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $14,199,000 | +58.7% | 106,528 | +85.7% | 3.90% | +6.4% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $14,137,000 | -18.6% | 171,082 | -6.3% | 3.88% | -45.4% |
| Sell | STEVANATO GROUP S P A | $13,077,000 | -7.0% | 771,933 | -13.2% | 3.59% | -37.7% | |
| SAVA | New | CASSAVA SCIENCES INCcall | $12,099,000 | – | 289,300 | +100.0% | 3.32% | – |
| GSK | New | GSK PLCsponsored adr | $12,052,000 | – | 409,503 | +100.0% | 3.31% | – |
| New | BAUSCH PLUS LOMB CORP | $10,746,000 | – | 700,525 | +100.0% | 2.95% | – | |
| MRTX | New | MIRATI THERAPEUTICS INC | $10,583,000 | – | 151,534 | +100.0% | 2.90% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $10,550,000 | – | 95,445 | +100.0% | 2.90% | – |
| SKIN | Sell | THE BEAUTY HEALTH COMPANY | $9,728,000 | -17.3% | 825,109 | -9.7% | 2.67% | -44.5% |
| ALLO | Buy | ALLOGENE THERAPEUTICS INC | $8,469,000 | +173.0% | 784,133 | +188.2% | 2.32% | +83.0% |
| RXDX | Sell | PROMETHEUS BIOSCIENCES INC | $7,294,000 | -18.7% | 123,599 | -61.1% | 2.00% | -45.5% |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $7,169,000 | – | 280,811 | +100.0% | 1.97% | – |
| AKRO | New | AKERO THERAPEUTICS INC | $7,125,000 | – | 209,248 | +100.0% | 1.96% | – |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $6,706,000 | +88.2% | 238,569 | +80.5% | 1.84% | +26.2% |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $6,121,000 | +124.5% | 636,943 | +69.2% | 1.68% | +50.5% |
| KZR | Buy | KEZAR LIFE SCIENCES INC | $6,111,000 | +46.5% | 709,733 | +40.7% | 1.68% | -1.8% |
| New | ASTRIA THERAPEUTICS INC | $5,709,000 | – | 631,579 | +100.0% | 1.57% | – | |
| NTRA | New | NATERA INC | $5,695,000 | – | 129,955 | +100.0% | 1.56% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $5,517,000 | – | 683,613 | +100.0% | 1.51% | – |
| XENE | Sell | XENON PHARMACEUTICALS INC | $4,849,000 | -4.2% | 134,331 | -19.3% | 1.33% | -35.8% |
| New | VENTYX BIOSCIENCES INC | $4,364,000 | – | 125,000 | +100.0% | 1.20% | – | |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $4,282,000 | +155.3% | 2,504,006 | +44.0% | 1.18% | +71.0% |
| INSP | Sell | INSPIRE MED SYS INC | $4,153,000 | -28.3% | 23,412 | -26.2% | 1.14% | -51.9% |
| ISEE | New | IVERIC BIO INC | $3,419,000 | – | 190,597 | +100.0% | 0.94% | – |
| BEAM | New | BEAM THERAPEUTICS INC | $2,561,000 | – | 53,754 | +100.0% | 0.70% | – |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $2,383,000 | – | 36,460 | +100.0% | 0.65% | – |
| BLU | Sell | BELLUS HEALTH INC NEW | $2,267,000 | -78.4% | 214,661 | -81.1% | 0.62% | -85.5% |
| ALT | Sell | ALTIMMUNE INC | $2,009,000 | -70.1% | 157,303 | -72.6% | 0.55% | -80.0% |
| PCVX | New | VAXCYTE INC | $1,906,000 | – | 79,411 | +100.0% | 0.52% | – |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INCcall | $1,682,000 | +37.2% | 199,500 | +28.7% | 0.46% | -8.0% |
| FGEN | New | FIBROGEN INC | $967,000 | – | 74,348 | +100.0% | 0.26% | – |
| New | ARCELLX INC | $804,000 | – | 42,826 | +100.0% | 0.22% | – | |
| LPTX | New | LEAP THERAPEUTICS INC | $626,000 | – | 711,798 | +100.0% | 0.17% | – |
| FEMY | Buy | FEMASYS INC | $120,000 | -40.6% | 106,606 | +27.2% | 0.03% | -60.2% |
| Exit | DOMA HOLDINGS INC | $0 | – | -21,974 | -100.0% | -0.01% | – | |
| ALGS | Exit | ALIGOS THERAPEUTICS INC | $0 | – | -29,302 | -100.0% | -0.01% | – |
| GATO | Exit | GATOS SILVER INC | $0 | – | -12,062 | -100.0% | -0.01% | – |
| AVAH | Exit | AVEANNA HEALTHCARE HLDGS INC | $0 | – | -15,151 | -100.0% | -0.01% | – |
| Exit | MARKFORGED HOLDING CORPORATI | $0 | – | -17,585 | -100.0% | -0.01% | – | |
| ME | Exit | 23ANDME HOLDING CO CLASS A | $0 | – | -14,367 | -100.0% | -0.02% | – |
| SKIL | Exit | SKILLSOFT CORPcl a | $0 | – | -10,891 | -100.0% | -0.02% | – |
| UP | Exit | WHEELS UP EXPERIENCE INC | $0 | – | -19,892 | -100.0% | -0.02% | – |
| LEV | Exit | THE LION ELECTRIC COMPANY | $0 | – | -10,466 | -100.0% | -0.02% | – |
| ADV | Exit | ADVANTAGE SOLUTIONS INC | $0 | – | -12,156 | -100.0% | -0.02% | – |
| CVM | Exit | CEL-SCI CORP | $0 | – | -11,206 | -100.0% | -0.02% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -13,402 | -100.0% | -0.02% | – |
| AVPT | Exit | AVEPOINT INC | $0 | – | -12,140 | -100.0% | -0.02% | – |
| STTK | Exit | SHATTUCK LABS INC | $0 | – | -13,230 | -100.0% | -0.02% | – |
| NG | Exit | NOVAGOLD RES INC | $0 | – | -11,433 | -100.0% | -0.02% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -20,029 | -100.0% | -0.03% | – |
| RIG | Exit | TRANSOCEAN LTD | $0 | – | -19,683 | -100.0% | -0.03% | – |
| NLY | Exit | ANNALY CAPITAL MANAGEMENT IN | $0 | – | -17,666 | -100.0% | -0.04% | – |
| MMM | Exit | 3M CO | $0 | – | -1,619 | -100.0% | -0.09% | – |
| Exit | AMYLYX PHARMACEUTICALS INC | $0 | – | -80,459 | -100.0% | -0.64% | – | |
| Exit | SCIENCE 37 HOLDINGS INC | $0 | – | -1,036,194 | -100.0% | -0.85% | – | |
| EOLS | Exit | EVOLUS INC | $0 | – | -217,767 | -100.0% | -1.03% | – |
| ACET | Exit | ADICET BIO INC | $0 | – | -183,857 | -100.0% | -1.10% | – |
| RVMD | Exit | REVOLUTION MEDICINES INC | $0 | – | -148,453 | -100.0% | -1.18% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -162,014 | -100.0% | -1.61% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -68,750 | -100.0% | -2.25% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -39,663 | -100.0% | -2.42% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INC | $0 | – | -111,572 | -100.0% | -2.61% | – |
| TCDA | Exit | TRICIDA INC | $0 | – | -731,142 | -100.0% | -2.90% | – |
| EVH | Exit | EVOLENT HEALTH INCcl a | $0 | – | -324,869 | -100.0% | -4.08% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -545,532 | -100.0% | -5.54% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FEMASYS INC | 10 | Q3 2023 | 0.5% |
| REGENERON PHARMACEUTICALS | 9 | Q3 2023 | 13.8% |
| LILLY ELI & CO | 9 | Q2 2023 | 9.5% |
| X4 PHARMACEUTICALS INC | 8 | Q3 2023 | 3.0% |
| XENON PHARMACEUTICALS INC | 8 | Q3 2023 | 2.4% |
| ARGENX SE | 7 | Q3 2023 | 12.8% |
| STEVANATO GROUP S P A | 7 | Q2 2023 | 5.8% |
| PROTAGONIST THERAPEUTICS INC | 7 | Q2 2023 | 7.1% |
| AVADEL PHARMACEUTICALS PLC | 7 | Q3 2023 | 6.4% |
| BELLUS HEALTH INC NEW | 7 | Q3 2022 | 4.3% |
View Tri Locum Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-27 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Tri Locum Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.